Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Tipifarnib and Naxitamab for Relapsed/Refractory NeuroblastomaNeoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Neuroectodermal Tumors, Primitive, Neuroectodermal Tumors, Primitive, Peripheral, epithelial neoplasm, neoplasm, neuroblastoma, neuroepithelial neoplasm, primitive neuroectodermal tumorRecruitingPhase 22026-09-03NCT06540963

1 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
Giselle Sholler7

12 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Arkansas Children's HospitalLittle RockUnited States82
Arnold Palmer Hospital for ChildrenOrlandoUnited States79
Cardinal Glennon Children's Medical CenterSt LouisUnited States54
Children's Medical CenterDallasUnited States8
Connecticut Children's HospitalHartfordUnited States10
Dell Children's Blood and Cancer CenterAustinUnited States7
Duke UniversityDurhamUnited States45
Kapiolani Medical Center for Women and ChildrenHonoluluUnited States9
Monroe Carrell Jr. Children's Hospital at VanderbiltNashvilleUnited States5
Nicklaus Children's HospitalMiamiUnited States112
Penn State Milton S. Hershey Medical Center and Children's HospitalHersheyUnited States11
Randall Children's HospitalPortlandUnited States7